ClinicalTrials.Veeva

Menu

Auditory Functions in Patients With Multiple Sclerosis

U

University of Catania

Status

Enrolling

Conditions

Hearing Disorders
Multiple Sclerosis

Treatments

Other: CSF sampling
Diagnostic Test: Auditory test

Study type

Observational

Funder types

Other

Identifiers

NCT06164483
MSSNHL2023

Details and patient eligibility

About

The study will analyze the auditory functions of patients with Multiple Sclerosis using auditory tests like pure tone auditory test, speech perception test, Auditory Brain Response (ABR) and Distortion Product Otoacustic Emission (DPOAE). CSF will be collected by lumbar puncture and analyzed looking for inflammatory markers.

The results of DPOAE and CSF will be correlated to identify statistically significant correlation.

Full description

Case-Control study

Tools for patients' selection and inclusion in the study

STEP one

  • Full medical records detailed for neurological diseases
  • Brain and spinal cord MRI performed 12 months (n1) before and most recent one (n2)
  • Lumbar puncture
  • Blood test
  • Questionnaire for screening hearing disorders
  • App for screening hearing loss

STEP two

  • Pure Tone Auditory test + Tympanometry and Stapedial Reflex
  • Speech Perception test
  • In case of tinnitus: tinnitus questionnaire and acuphenometry
  • DPOAEs
  • ABR

STEP three in case of Hearing impairment

  • MRI Tractography

Enrollment

30 estimated patients

Sex

All

Ages

20 to 40 years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria

  • age >18 and <50,
  • no history of hearing loss,
  • no psychiatric condition
  • no familial history of otosclerosis/deafness/genetic hearing loss
  • patients with PD and/or MS.

Exclusion Criteria

  • Conductive hearing loss
  • stroke < 2 years
  • cardiovascular disease non under control
  • diabetes
  • hypotensive disorders
  • alcohol abuse
  • recreational drug consumption
  • epilepsy

Trial design

30 participants in 2 patient groups

Control
Description:
Healthy patients between 20 and 40 years
Treatment:
Diagnostic Test: Auditory test
Other: CSF sampling
MS group
Description:
Patient with Relapsing Remitting MS age between 20 and 40 years
Treatment:
Diagnostic Test: Auditory test
Other: CSF sampling

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems